✦ LIBER ✦

Phase II trial of erlotinib in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations: additive analysis of pharmacokinetics

✍ Scribed by Motoshima, Kohei; Nakamura, Yoichi; Sano, Kazumi; Ikegami, Yoji; Ikeda, Takaya; Mizoguchi, Kosuke; Takemoto, Shinnosuke; Fukuda, Minoru; Nagashima, Seiji; Iida, Tetsuya; Tsukamoto, Kazuhiro; Kohno, Shigeru

Book ID: 121602465
Publisher: Springer
Year: 2013
Tongue: English
Weight: 227 KB
Volume: 72
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-013-2307-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II trial of vorinostat (SAHA) an

Phase I/II trial of vorinostat (SAHA) and erlotinib for non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations after erlotinib progression

✍ Reguart, Noemi; Rosell, Rafael; Cardenal, Felipe; Cardona, Andres F.; Isla, Dolo 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 645 KB

A phase II trial of gefitinib as first-l

A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations

✍ Asahina, H; Yamazaki, K; Kinoshita, I; Sukoh, N; Harada, M; Yokouchi, H; Ishida, 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 139 KB

Prospective Phase II Study of Gefitinib

Prospective Phase II Study of Gefitinib for Chemotherapy-Naive Patients With Advanced Non-Small-Cell Lung Cancer With Epidermal Growth Factor Receptor Gene Mutations

✍ Inoue, A. 📂 Article 📅 2006 🏛 American Society of Clinical Oncology 🌐 English ⚖ 262 KB

Prospective phase II study of gefitinib

Prospective phase II study of gefitinib in non-small cell lung cancer with epidermal growth factor receptor gene mutations

✍ Sugio, Kenji; Uramoto, Hidetaka; Onitsuka, Takamitsu; Mizukami, Makiko; Ichiki, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Single-agent gefitinib with concurrent r

Single-agent gefitinib with concurrent radiotherapy for locally advanced non-small cell lung cancer harboring mutations of the epidermal growth factor receptor

✍ Okamoto, Isamu; Takahashi, Toshiaki; Okamoto, Hiroaki; Nakagawa, Kazuhiko; Watan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Phase II Clinical Trial Data with the Ep

Phase II Clinical Trial Data with the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib (OSI-774) in Non–Small-Cell Lung Cancer

✍ Romàn Pérez-Soler 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 144 KB